Ketamine and GHB: new trends in club drug use?

References

• Ahmed SN and Petchkovsky L (1980) Abuse of ketamine (Letter). British Journal of Psychiatry 137 (Sept): 303.
   PubMed Web of Science ®Google Scholar
• Anon (1999) Adverse events associated with ingestion of gamma-butyrolactone — Minnesota, New Mexico and Texas, 1998-1999. MlVIWR — Morbidity and Mortality Weekly Report 48: 137–40.
   Google Scholar
• Australian Bureau of Criminal Intelligence (ABCI) (1995) Australian Illicit Drug Report 1994. Australian Bureau of Criminal Intelligence: Canberra.
   Google Scholar
• Australian Bureau of Criminal Intelligence (ABCI) (2000) Australian Illicit Drug Report 1998–99. Australian Bureau of Criminal Intelligence: Canberra.
   Google Scholar
• Australian Institute of Health and Welfare (1999) 1998 National Drug Strategy Household Survey. First results. Australian Institute of Health and Welfare: Canberra.
   Google Scholar
• Centers for Disease Control (1997) Gamma hydroxybuty-rate use in New York and Texas, 1995-1996. Journal of the American Medical Association 277: 1511.
   Google Scholar
• Chin M, Kreutzer RA and Dyer JE (1992) Acute poisoning from gamma-hydroxybutyrate in California. Western Journal of Medicine 156: 380–4.
   PubMedGoogle Scholar
• Collier BB (1972) Ketamine and the conscious mind. Anaesthesia 27 (2): 120–34.
   PubMedGoogle Scholar
• Dalgarno PJ and Shewan D (1996) Illicit use of ketamine in Scotland. Journal of Psychoactive Drugs 28 (2): 191–9.
   PubMed Web of Science ®Google Scholar
• Dillon P (2000) Bopping till they drop? Drugs and the gay scene. Connexions December 1999/January 2000: 10–11.
   Google Scholar
• Dillon P. Copeland J and Jansen K (2001) Patterns of use and harms associated with non-medical ketamine use. Technical Report No 111. National Drug and Alcohol Research Centre: Sydney.
   Google Scholar
• Domino EF, Chodoff P and Corssen G (1965) Phar-macologic effects of CI-581, a new dissociative anaesthetic, in man. Clinical and Pharmacological Therapeutics 6: 279–91.
   PubMed Web of Science ®Google Scholar
• ElSohly MA and Salamone SJ (1999) Prevalence of drugs used in cases of alleged sexual assault. Journal of Analytical Toxicology 23 (3): 141–6.
   PubMed Web of Science ®Google Scholar
• Ferrara SD, Tedeschi L, Frison G and Rossi A (1995) Fatality due to gamma hydroxy butyric acid (GHB) and heroin intoxication. Journal of Forensic Sciences 40: 501–4.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (1997) FDA re-issues warning on GHB, February 18, 1997. US Department of Health and Human Services: Rockville.
   Google Scholar
• Galloway GP, Frederick SL, Staggers Jr FE, Gonzales M, Stalcup SA and Smith D (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92: 89–96.
   PubMed Web of Science ®Google Scholar
• Hernandez M, McDaniel CH, Costanza CD and Hernan-dez OJ (1998) GHB-induced delirium: a case report and review of the literature on gamma hydroxybutyric acid American Journal of Drug and Alcohol Abuse 24 (1): 179–83.
   PubMed Web of Science ®Google Scholar
• Jansen KLR (1993) Non-medical use of ketamine (Letter). British Medical Journal 306 (6878): 601–2.
   PubMed Web of Science ®Google Scholar
• Jansen KLR (1997) Questions and Answers: Ketamine. Drug News Summer 1997: 19–21.
   Google Scholar
• Jansen KLR (2000) Ketamine, Dreams and Realities. Multidisciplinary Association for Psychedelic Studies: Florida.
   Google Scholar
• Kam PCA and Yoong FFY (1998) Gamma-hydroxybutyric acid: an emerging recreational drug (Special Commu-nication). Anaesthesia 53 (12): 1195–8.
   PubMed Web of Science ®Google Scholar
• Licata M, Pierini G, and Popoli G (1994) A fatal ketamine poisoning. Journal of Forensic Science 39 (5): 1314–20.
   PubMed Web of Science ®Google Scholar
• McKetin R, Darke S, Humeniuk R, Dwyer R, Bruno R, Fleming J, Kinner S, Hargreaves K and Rysavy P (2000) Australian Drug Trends 1999. Findings from the Illicit Drug Reporting System (IDRS). Monograph No 43. National Drug and Alcohol Research Centre: Sydney.
   Google Scholar
• Michael GW and Hall JN (1994) South Florida at risk from Grievous Bodily Harm. Information for Action. Drug Surveillance News May 9. Florida Department of HRS: Florida.
   Google Scholar
• New York State Office of Alcoholism and Substances Abuse Service (1997) Ketamine Update. Bureau of Applied Studies — Street Studies Unit: New York.
   Google Scholar
• Parke-Davis (1999–2000) Parke-Davis Product Information Sheet: Ketalar. ABPI Compendium of Data Sheets and Summaries of Product Characteristics, 1999–2000. Dataphami Publications.
   Google Scholar
• Radford P (1996) Ketamine: the forgotten anaesthetic? Australian Journal of Rural Health 4: 137–9.
   Google Scholar
• Reier C (1971) Ketamine — 'dissociative agene or hallucinogen? (Letter). New England Journal of Medicine 284 (14): 791–2.
   PubMed Web of Science ®Google Scholar
• Siegel RK (1978) Phencyclidine and ketamine intoxication: A study of four populations of recreational users. In: Peterson RC and Stillman RC (eds) Phencyclidine Abuse: An Appraisal. NIDA Research Monograph No 21. National Institute on Drug Abuse: Rockvile, Maryland.
   Google Scholar
• Solowij N, Hall W and Lee N (1992) Recreational MDMA use in Sydney. A profile of 'Ecstasy' users and their experiences with the drug. British Journal of Addiction 87: 1161–72.
   PubMedGoogle Scholar
• Stafford P (1992) Psychedelics Encyclopedia. 3rd Edition. Ronin Publishing: Berkeley, California.
   Google Scholar
• Tolliver JM (1997) Gamma-hydroxybutyrate (GHB). Drug Enforcement Administration.
   Google Scholar
• Topp L, Hando J, Degenhardt L, Dillon P. Roche A and Solowij N (1998) Ecstasy Use in Australia. Monograph No 39. National Drug and Alcohol Research Centre: Sydney.
   Google Scholar
• Tori SP (1996) Ketamine Abuse 'Special K'. Middle Atlantic-Great Lakes Organized Crime Law Enforcement Network (MAGLOCLEN): Pennsyl-vania.
   Google Scholar
• Vickers MD (1968) Gamma hydroxybutyric acid. Proceed-ings of Royal Society of Medicine 61: 821–3.
   PubMedGoogle Scholar
• Young LA, Young LG, Klein MM, Klein DM and Beyer D (eds) (1997) Recreational Drugs. Collier Books: New York.
   Google Scholar